Sidebar

services

Rapolas Zilionis  


Email:


LinkedIn

 

Research Group
Research Interests: Droplet microfluidics
Single-cell sequencing
Molecular biology method development 
Present Position: Senior researcher, Sector of Microtechnologies, Institute of Biotechnology, Life Sciences Center, Vilnius University
Chief Scientific Officer, Droplet Genomics 
Education:
 2019 - PhD in Physical sciences (Biochemistry), Vilnius University
2014 - MSc in Biochemistry, Vilnius University
2012 - BSc in Biochemistry, Vlnius University 
Experience (Past Positions): 2014–present - Researcher, Sector of Microtechnologies, Life Sciences Center, Vilnius University, Lithuania
2019–present - CSO, Droplet Genomics, Lithuania
2015–2018 - Visiting Fellow, Harvard Medical School, USA
July–October 2013 - Intern, Ludwig Institute for Cancer Research, Oxford University, UK
2010–2014 - Research Assistant, ThermoFisher Scientific Baltics, Lithuania 
Single-cell RNAseq data analysis with Python 
Awards: 2020 Winner in Young Scientist Best Research Work competition – Lithuanian Academy of Sciences
2019 Vilnius University Rector's award 
2019 Award for Best Publication of 2018 in the field biomedicine – Vilnius University 
Publications: LABT_LMAVB 
GoogleScholar

Projects and Grants:

As lead investigator:
13.1.1-LMT-K-718-05-0004 Development of a highly sensitive digital RT-PCR method for absolute quantification of SARS-CoV-2 virus.

As executor:
2020–2021 - 01.2.2-LMT-K-718-04-0002 "Establishment of a parallel laboratory for single-cell transcriptomic-genomic research". 
2018–2020 - 09.3.3-LMT-K-712-01-0056 "Microfluidic technologies for genotype-phenotype studies of single cells".
2017 - S-MIP-17-58 "Single-cell technology for genomic DNA modification study and analysis of neuroblastoma epigenetic heterogeneity".
2014–2015 - CH-3-ŠMM-01/03 "Evolution of computer-modeled enzymes using microfluidic technologies".
2018–2019 - NIH R01-CA218579, "Single-cell genome-wide myeloid response profiling in immunotherapy".
2017–2018 - NIH R33-CA212697-01, "Droplet microfluidic technology for single-cell cancer genomics".
Languages: Lithuanian (native), English, French, Russian

 

Research